Free Republic
Browse · Search
News/Activism
Topics · Post Article

Skip to comments.

Fauci’s NIAID Hid Plans to Create Mutant Monkeypox Virus that ‘Could’ve Started Pandemic’
https://legalinsurrection.com/2024/06/faucis-niaid-hid-plans-to-create-mutant-monkeypox-virus-that-couldve-started-pandemic/ ^ | 5/30/2024 | Leslie Eastman

Posted on 07/06/2024 9:02:48 AM PDT by cuz1961

... a congressional report has revealed that Fauci’s National Institute of Allergy and Infectious Diseases (NIAID) deceived Congress over its plans to create a Frankenstein monkeypox virus ...

... this would be classified as gain-of-function, which is research that can result in deadlier and more transmissible viruses and is feared to be behind the creation of Covid....

(Excerpt) Read more at legalinsurrection.com ...


TOPICS: Crime/Corruption; Government; News/Current Events; Politics/Elections
KEYWORDS: defundniaid; gainoffunction; monkeypox; virus
Navigation: use the links below to view more comments.
first previous 1-2021-38 last
To: cuz1961
Patriots welcome Fauci to Culver City, Calif.

"Fauci lied! People died!"

21 posted on 07/06/2024 9:56:18 AM PDT by Fiji Hill
[ Post Reply | Private Reply | To 1 | View Replies]

To: thegagline

hes probably been awarded alot in his career.

\/

??

https://patents.justia.com/inventor/anthony-s-fauci

\\\

Patents by Inventor Anthony S. Fauci
Anthony S. Fauci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

///

Justia Patents Anthony S. Fauci Inventions, Patents and Patent Applications

Patents by Inventor Anthony S. Fauci
Anthony S. Fauci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Use of antagonists of the interaction between HIV GP120 and ?4?7 integrin
Patent number: 9896509
Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV.
Type: Grant
Filed: August 3, 2016
Date of Patent: February 20, 2018
Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services
Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci
USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND A4B7 INTEGRIN
Publication number: 20160333097
Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV.
Type: Application
Filed: August 3, 2016
Publication date: November 17, 2016
Applicant: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Serv
Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci
Use of antagonists of the interaction between HIV GP120 and ?4?7 integrin
Patent number: 9441041
Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV.
Type: Grant
Filed: September 21, 2015
Date of Patent: September 13, 2016
Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services
Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci
USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND A4B7 INTEGRIN
Publication number: 20160075786
Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV.
Type: Application
Filed: September 21, 2015
Publication date: March 17, 2016
Applicant: The United States of America, as Represented by the Secretary, Department of Health and Human Serv
Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci
IMMUNOCONJUGATES COMPRISING CD4 AND IMMUNOGLOBIN MOLECULES FOR THE TREATMENT OF HIV INFECTION
Publication number: 20090285815
Abstract: Nucleic acids encoding recombinant CD4-fusion proteins are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. The portion of the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C terminus of the heavy chain of an IgA antibody or a tailpiece from a C terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4-fusion proteins.
Type: Application
Filed: March 21, 2008
Publication date: November 19, 2009
Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci
Fusion protein including of CD4
Patent number: 7368114
Abstract: Novel recombinant polypeptides are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. The portion or the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C-terminus of the heavy chain of an IgA antibody ara tailpiece from a C-terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4 fusion proteins.
Type: Grant
Filed: October 24, 2002
Date of Patent: May 6, 2008
Assignee: The United States of America as represented by the Department of Health and Human Services
Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci
HIV related peptides
Patent number: 6911527
Abstract: This invention is the discovery of novel specific epitopes and antibodies associated with long term survival of HIV-1 infections. These epitopes and antibodies have use in preparing vaccines for preventing HIV-1 infection or for controlling progression to AIDS.
Type: Grant
Filed: January 7, 2000
Date of Patent: June 28, 2005
Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
Inventors: Giuseppe Scala, Xueni Chen, Oren J. Cohen, Anthony S. Fauci
Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4
Publication number: 20040265306
Abstract: Novel recombinant polypeptides are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. The portion of the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C-terminus of the heavy chain of an IgA antibody or a tailpiece from a C-terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4-fusion proteins.
Type: Application
Filed: July 27, 2004
Publication date: December 30, 2004
Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci
Immunologic enhancement with intermittent interleukin-2 therapy
Publication number: 20030180254
Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value. This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy.
Type: Application
Filed: January 23, 2003
Publication date: September 25, 2003
Applicant: The Govt. of the USA as represented by the Secretary of the Dept. of Health & Human Services
Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci
Immunologic enhancement with intermittent interleukin-2 therapy
Patent number: 6548055
Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value. This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy.
Type: Grant
Filed: August 9, 2000
Date of Patent: April 15, 2003
Assignee: The United States of America as represented by the Department of Health and Human Services
Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci
Immunologic enhancement with intermittent interleukin-2 therapy
Patent number: 6190656
Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value. This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy.
Type: Grant
Filed: September 2, 1997
Date of Patent: February 20, 2001
Assignee: The United States of America as represented by the Department of Health and Human Services
Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci
Immunologic enhancement with intermittent interleukin-2 therapy
Patent number: 5696079
Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value. This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy.
Type: Grant
Filed: May 26, 1995
Date of Patent: December 9, 1997
Assignee: The United States of America as represented by the Department of Health and Human Services
Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci

\/

there was a documentry vid by a guy who reasearched all the patents and royalties back all the way to the 80’s iirc.

it was 2 or 3 hours.
i think i posted it back in the day

..


22 posted on 07/06/2024 9:57:15 AM PDT by cuz1961 (USCGR 78/84)
[ Post Reply | Private Reply | To 15 | View Replies]

Comment #23 Removed by Moderator

To: vetvetdoug

We need to kill Fauci

\\\

no.

he needs to be investigated, charged and given a fair trial.


24 posted on 07/06/2024 10:30:40 AM PDT by cuz1961
[ Post Reply | Private Reply | To 23 | View Replies]

To: vetvetdoug

are you helping tony to get some death threats he can hide behind ?


25 posted on 07/06/2024 10:32:43 AM PDT by cuz1961
[ Post Reply | Private Reply | To 23 | View Replies]

To: cuz1961

The idea was to create all kinds of scary-sounding supposedly pandemic-able “viruses” that could be psyoped on the world, with the follow-on jabs to be the real bioweapons, killing plenty on their own if simply transfected RNA or transformed DNA, but also with toxic LNPs and the like AND a synthetic genomic sequence that could plausibly be explained as dangerous.

Other weapons at their disposable are bacteria that can spread, heavy metals and other toxins that can be spread by environment, food, etc. But RNA viruses that can cause a pandemic? There’s no evidence that they’ve been able to create that at all. (Hat tip: JJ Couey)


26 posted on 07/06/2024 10:38:48 AM PDT by 9YearLurker
[ Post Reply | Private Reply | To 1 | View Replies]

To: 9YearLurker

*disposal*


27 posted on 07/06/2024 10:39:23 AM PDT by 9YearLurker
[ Post Reply | Private Reply | To 26 | View Replies]

To: cuz1961

Didn’t realize I’d get Zapped by the Viking Kitties. Tony is trying to kill many of us and is a threat to many with his overt dangerous actions.


28 posted on 07/06/2024 10:39:29 AM PDT by vetvetdoug
[ Post Reply | Private Reply | To 25 | View Replies]

To: thegagline; nonliberal

Yes, AIDS as caused by the HIV virus was a fiction. Jabs, other dangers (e.g., risky drug and sex-related behaviors), and treatments for such were among the many quivers in their bows.


29 posted on 07/06/2024 10:41:36 AM PDT by 9YearLurker
[ Post Reply | Private Reply | To 17 | View Replies]

To: cuz1961

he needs to be publicly burned at he stake


30 posted on 07/06/2024 10:47:31 AM PDT by ronnie raygun
[ Post Reply | Private Reply | To 1 | View Replies]

To: cuz1961

Hey, and everybody who worked with him, as well as those who were above him and ordered this kind of thing to be done, need to face a Nuremberg style trial for crimes against humanity. Then, when found guilty, they need to be drawn and quartered - ALL of them. Their bio labs must be incinerated with all of their contents.


31 posted on 07/06/2024 11:16:05 AM PDT by Ancesthntr ("The right to buy weapons is the right to be free." - The Weapons Shops of Isher)
[ Post Reply | Private Reply | To 1 | View Replies]

To: cuz1961
Even Dr. Mengele wasn't as evil as Fauci. Unfortunately, unlike Mengele, Fauci is still alive.

32 posted on 07/06/2024 11:41:53 AM PDT by Governor Dinwiddie (LORD, grant thy people grace to withstand the temptations of the world, the flesh, and the devil.)
[ Post Reply | Private Reply | To 1 | View Replies]

To: vetvetdoug
Viking Kitties

\/

i asked for your post to be removed, so that wpuld make me the viking kittie.

im sorry, but fauci has been hiding behind death threats ,, and your post came to close to being that immo..

pretty sure i hate,, yes feddies i said hate, fauci more than you.

but we are not mobocrats, or more accurately

we are not

lynchmobocrats

.

he needs to be investigated, charged and given a fair trial ,

criminally and civilly .....if found guilty ....reparations and capital punishment would please me greatly. .

33 posted on 07/06/2024 11:46:02 AM PDT by cuz1961
[ Post Reply | Private Reply | To 28 | View Replies]

To: JimRed

Just don’t look eye to eye to anyone while wearing the mask!


34 posted on 07/06/2024 11:46:43 AM PDT by TribalPrincess2U (Bye done!)
[ Post Reply | Private Reply | To 6 | View Replies]

To: cuz1961

In a sane world, this fool would be tried for crimes against humanity, found guilty and hanged the next day.


35 posted on 07/06/2024 1:36:22 PM PDT by wjcsux (On 3/14/1883 Karl Marx gave humanity his best gift, he died. )
[ Post Reply | Private Reply | To 1 | View Replies]

To: cuz1961

btt


36 posted on 07/06/2024 2:36:08 PM PDT by GailA (Land Grabs, Poisoned Food, KILL the COWS, Bidenomics=BIDEN DEPRESSION. STAGNATION)
[ Post Reply | Private Reply | To 1 | View Replies]

To: cuz1961

I would like nothing more than to treat little anthony mengele fauci the same way he treated those beagles.


37 posted on 07/06/2024 7:40:33 PM PDT by 2CAVTrooper (Freedom is the sure possession of those alone who have the courage to defend it.)
[ Post Reply | Private Reply | To 1 | View Replies]

To: All

World Health Organization declares ultra-deadly monkeypox 2024 strain (now PC reported as “MPox”) a public health emergency of international concern

https://www.dailymail.co.uk/health/article-13743701/world-health-organization-deadly-mpox-strain-emergency.html

From the CDC:
https://www.cdc.gov/nchhstp/director-letters/monkeypox-considerations-sexual-health-services.html


38 posted on 08/14/2024 11:32:05 AM PDT by Texan4Life
[ Post Reply | Private Reply | To 37 | View Replies]


Navigation: use the links below to view more comments.
first previous 1-2021-38 last

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
News/Activism
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson